NCT04933903
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Rhode Island Hospital Providence, Rhode Island, United States
Clinical trial condition
Lung Neoplasms
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
4,211 public trials
1,007 recruiting studies
Lung Neoplasms trial results
NCT05655078
- Conditions
- Adenoma, Lung Diseases, Lung Neoplasms, +12 more
- Locations
-
- East Sussex Healthcare NHS Trust - Eastbourne Hospital Eastbourne, East Sussex, United Kingdom
- East Sussex Healthcare NHS Trust - Conquest Hospital Saint Leonards-on-Sea, East Sussex, United Kingdom
- Royal Berkshire Hospital Reading, England, United Kingdom
- Southend University Hospital Southend, Essex, United Kingdom
NCT06769126
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Carcinoma, +12 more
- Locations
-
- Loma Linda University Medical Center Loma Linda, California, United States
- Eisenhower Medical Center Rancho Mirage, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
NCT05837767
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
Recruiting
KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC
NCT05254184
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Johns Hopkins University Baltimore, Maryland, United States
Recruiting
Phase 2 Study of Fingolimod in Lung Cancers
NCT06424067
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Hollings Cancer Center at Medical University of South Carolina Charleston, South Carolina, United States
NCT07055581
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
- Locations
-
- The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital Zhengzhou, Henan, China
- Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT07189871
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +60 more
- Locations
-
- Dothan Hematology & Oncology Dothan, Alabama, United States
- BAMF Health Grand Rapids, Michigan, United States
- Nebraska Cancer Specialists Omaha, Nebraska, United States
- XCancer Omaha, Nebraska, United States
NCT06687941
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +21 more
- Locations
-
- National Cancer Center, Korea Goyang-si, Gyeonggi-do, South Korea
- CHA Bundang Medical Center Seongnam, South Korea
- Severance Hospital Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
NCT07478809
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China